Introduction: Generic medicines are produced by multiple manufacturers hence, are usually cheaper than innovator brands and therefore save costs on medicines. Many physicians oppose brand substitution, believing generic medicines to be inferior to their originator counterparts. Physicians' belief about generic medicines and factors affecting generic prescribing in Ethiopia are poorly investigated. Objective: To assess the physicians' belief about generic medicines and to identify factors affecting generic medicines prescribing in private health facilities, Mekelle, Northern Ethiopia. Materials and Methods: An institution based cross-sectional study was conducted enrolling all physicians working in private health facilities. The data were collected from January 2016 to March 2016. Data were collected using self-administered structured questionnaires measuring generic medicines belief of physicians using a Likert scale of 1-5. Data were then entered into SPSS version 20 for analysis. Results: Of the fifty-six physicians approached in this study, 50 (89.2% response rate) questionnaires were included in the analysis. Nearly three-fourth (72%) of the physicians claimed that they always prescribe generic medicines. More than half (55.3) of the respondents beliefs generic medicines have different active ingredients than a brand innovator. Almost equal percentage (52% and 54%) of the Physicians disagreed with brand medicines were safer than generic medicines and prescribing generic due to the complicated health problem of the patient respectively. Around two third (67.5%) of physicians reported that quality profile of medicine was a major reason for prescribing generic medicines. Moreover, availability of medicines in pharmacies and low cost of medicines were the main reasons for prescribing generic medicines with 58.1% and 52.4% respectively. Conclusion: The majority of physicians do not have a positive perception of generic medicines and a significant portion of the physician's belief brand medicines safer and effective than generic counterparts. The availability of medicines in pharmacies, low cost of medicines and purchasing power of the patients are major factors affecting generic medicines prescribing.
INTRODUCTION
A generic medicine is a product that can be interchangeable with the innovator product, which does not need a license from the innovator, and manufactured after the expiration of the patent or other exclusivity rights. [1] [2] [3] In order to be approved, a generic medicine should be bioequivalent to the originator product, and must be the same in terms of strength, safety and quality 1, 4, 5 while generic medicines could differ from their equivalent branded medicine in their color, size, shape and excipient ingredients, they must be able to demonstrate bioequivalence to the originator medicine in terms of bioavailability and the rate of absorption. 2, 6 Generic medicines are produced by multiple manufacturers hence, are usually cheaper than innovator brands and therefore save costs on medicines. 1, 4, 5 Study conducted in 17 developing countries reported an average of 9-89% expenditure could be saved by each country in private sector purchases by switching from originator brands to lowest-priced generics. 5 Generic formulations offer the same therapeutic effect as branded medicines at a much more lowest price. 7 Because of this, generic drugs have been dramatically popular as a method to reduce pressure on drug budgets, and they now make up a significantly increasing percentage of consumed drugs. 8 Many physicians oppose brand substitution, believing generic medicines to be inferior to their originator counterparts. 9 In the UK, there was strong opposition when planned to introduce generic replacement into UK primary care. 10 However, Public and private third-party payers and health care regulatory authorities increasingly encourage or obligate the use of generics through measures such as generic prescribing and generic substitution.
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The use of generics has increased significantly in the last two decades. Although generic prescribing by physicians, is advocated in most countries, the extent to which this is put to practice differs significantly as do monitoring and evaluation by health insurance companies 16, 17 and generic substitution laws. 18 Generic drug prescription policies differ from country to country globally. The practice of generic medicines prescribing and substitution in developing countries has been controversial among healthcare professionals, principally due to issues on quality, safety and efficacy. 19 The use of generics is therefore often promoted in the public and private sectors to save medicine expenditure, and enhance product availability and client access. 20 In Ethiopia, clinical practice guidelines enforce a prescription should be using generic names of the medicine(s). 21 Private health care at present, accounts for over two thirds of total healthcare expenditure 22, 23 and over 70% of the entire expenditure on pharmaceuticals. 24 Currently, there is limited prescribing of generics specifically in the private sector, for instance. a study revealed over 90% of patients in the private sector typically demand originators and prices of generics vary from 0.2 to 7.02 times that of international market reference prices among a basket of products. 23, 25 The prescribing behavior of physicians is considered to be crucial for generic utilization as they determine whether their patients require branded drugs or generic drugs. 26 A generic medicine may not always be suitable for the patient. 27 Several factors may significantly influence the physicians prescribing behavior such as the trust and the quality image of the manufacturer company. 28 Physicians' prescribing practice can also be influenced by pharmaceutical manufacturers through a variety of incentives such as high-end education programs or even some cash payment for prescriptions. 29 In addition, free samples and gifts can also be provided 30 so that a targeted drug's name stays topmost in subconscious mind of the prescribers. 31 Therefore, these incentives may indirectly influence the patients, by encouraging them to use costly originator products instead of in the same way effective, lower-cost generics. 32 Globally, physicians are much more responsive to arguments about a drug's effectiveness than about its price. 33 Physicians with better education, better training on rational drug use and better possession of medicine understanding prescribe a lower percentage of generic drugs. 34 Physicians' belief about generic medicines and factors affecting generic prescribing in Ethiopia are poorly investigated. Therefore, this study narrows the knowledge gap and the findings of the current study assist policy makers regarding generic prescribing in the future. The main objective of the study was to assess physicians' belief about generic medicines and to identify factors affecting generic medicines prescribing in private health facilities, Mekelle, Ethiopia.
METHODS AND MATERIALS
The study was conducted in Mekelle city is main city of Tigray regional state, Ethiopia. Mekelle city is found at 783 Km Northeast of Addis Ababa, which is the capital of Ethiopia. Mekelle city has one comprehensive specialized referral hospital, three general hospitals, three private hospitals, sixty-three private clinics and nine health centers. This institution-based cross sectional study was conducted from January 13, 2016 to March 20, 2016.
All physicians (56) working in private health facilities were considered as the study population. Physicians inclusion criteria were experience of 6 months or greater in Mekelle city, whereas the exclusion criteria were unwilling to participate in the study and unable to fill out the questionnaire.
Data
were collected using self-administered questionnaire. The questionnaire had three different sections. The first part of the questions addresses socio demographic characteristics of respondents which followed by questions about generic medicines belief and finally questions about the reason for prescribing generic medicines were included. One day training was given to data collectors and supervisors on how to collect data from the respondents. Pretest was done on 5% of the questionnaires at Quiha hospital, which were not the part of the study area and the result was not
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[46] CODEN (USA): JDDTAO included. Daily on the spot-checking of filled questionnaires for errors or any incompleteness was done by holding daily discussions among data collectors.
The collected data were entered, cleaned and analyzed using SPSS version 20 statistical software. Frequencies and percentages were done for categorical variables. The normality of the population distribution was checked with histogram for continuous variables, for nonnormally distributed population the measure of central tendency (median) and a measure of dispersion (interquartile range) was reported.
Ethical clearance was obtained from Ethical Review Committee of College of Health Sciences, Mekelle University. Written permission was also obtained from the Tigray Regional Health Bureau, Mekelle city Health office and informed consent was obtained from individual respondents. Participants' information which gets from the questionnaires was kept confidential. Participants were also informed that participation was voluntary and they had right to refuse answering to any of the questions.
RESULTS
Of the 56 physicians working in a private health facility, 50 of them were voluntary to participate in this study which made a response rate of 89.2%. Forty six (92%) of physicians were males with Median age of 32 years and with an Inter quartile range (IQR) of 12. Among all respondents 28 (56%) and 22 (44 %) were married and were specialists respectively. Nearly half (48%) of the study participants have had an experience of less than or equal to five years (Table 1 ). Approximately three fourth (72%) of the physicians reported that they always prescribe generic medicines while 28% of respondents were neutral or disagree to prescribe generics (Figure 1 ).
Above half (55.3%) of the study participants reported that they believe that generic medicines have different active ingredients to that of brand medicines and almost equal percentage (52% and 54%) of the respondents disagreed with brand medicines were safer than generic medicines and prescribing generic due to the complicated health problem of the patient respectively. Twenty six (52%) of the physicians believed that locally produced drugs were equally effective as the brand products. In addition, nearly three fourth (72%) of the study participants strongly disagreed or disagreed with the concept of brand medicines were cost effective than generic counterparts (Table 2) . Around two third (67.5%) of physicians claimed that quality profile of medicine were major reason for prescribing generic medicines while the majority of respondents declared that they disagreed with the statement "I prescribe generic medicines due to peer norms". Approximately equal (58.1 and 52.4) percent of respondents agreed with availability of medicines in pharmacies and low cost of medicines were among the main reasons for prescribing generic medicines (Table  3) . More than half (52%) of the study participants believed that they were prescribed brand medicines on the basis of purchasing power of the patients. Above half 27 (58%) of the physicians strongly agreed or agreed that they prescribe brand medicines due to the influence of medical representative (Figure 2 ).
Chi-square test was done to see the association between the dependent and various independent variables by considering p-value of 5% significant level. As 
DISCUSSIONS
From the current study 72% of physicians claimed that they always prescribe generic medicine, which is slightly lower than the study finding in Ghana which revealed 79.2 % of medicines prescribed by generic name, the reason for the difference of the two finding may be a study conducted in Ghana only consider antibiotic but the current study couldn't specify medicine group, the other study conducted in Jordan depicted that from the physician's 62.8% (often) and 14.6% (very often) prescribe generic medicine instead of an originator brand which is comparable with our findings. 35, 36 In the current study, 28% of physician claimed that brand medicines are safer than generic medicine which is comparable with one systematic review that showed a greater proportion of doctors (836/2928, 28.54%, 95%) believed that generic medicines are equally safer with brand medicine. In this review significantly higher proportion of physicians held the view that generic drugs were less effective than their brand name equivalents (1450/5056; 28.68%) but in the current study, 34% of physician's couldn't accept locally produced medicines as equally effective as original brand medicines. Their view on the quality profile of the medicine might be the reason for such response. 8 One study done in Nigeria depicted that 105 (68.2%) respondents would prefer to recommend generic medicines over branded ones, while 49 (31.8%) respondents preferred to recommend branded medicines over generics in their practice. 37 The current study reported 11.4% of the participants claimed that generic medicines are similar to a brand counterpart in all aspects but 80.2% couldn't accept this similarity. A study conducted in Pakistan Punjab showed 53% physicians consider the Socio-economic status of the patient to prescribe medicine, a similar study reported 35% of a physician at Khyber Pakhtonkhwe(KPK). 38 In the current study, 52% of the study participants believed that they were prescribed brand medicines on the basis of purchasing power of the patients which is comparable with that of Punjab and higher than KPK's finding. Another study in Malaysia revealed cost of drugs 31(88.6%) and socio-economics status of the patients 16(45.7%) are factors that influences clinicians prescribing intent; this is lower than that of the current study likewise, the study was done in Jordan showed 58.5% of physician's believed that the cost is important, 10.6% believed that the cost is highly important, whereas 30.9% of the physicians believed that the cost is not important at all but the result of Jordan study also a bit higher than from that of our study. 35, 39 The difference in study participants, sample size and medicine specification could be the probable reason for the difference in findings. From the current study above half 27 (58%) of the physicians strongly agreed or agreed that they prescribe brand medicines due to the medical representative influence which is higher than the study conducted previously in similar study area which reports 40 (48.2%) of the physicians believed that their prescribing behaviors were influenced by visits of MRs and reports from Kentucky physicians indicated that they used information supplied by pharmaceutical representatives in their clinical practice 5.4% daily, 31.3% weekly, 47.7% monthly, and 14.4% yearly. 31, 40 A systematic review that scrutinizes this area figure out all randomized control trials (100 %) showed nonsignificant differences between generic and brand-name drugs. The aggregate effect size was 0.01 (95 % CI -0.05; 0.08) for soft outcomes; -0.06 (95 % CI -0.71; 0.59) for hard outcomes, both indicating no difference between generic and brand-name drugs. Much the same results were observed for each drug class and in each stratified meta-analysis. 1 But, in our study, only 11.4% of participants believed generic medicines are similar to a brand counterpart in all aspects. In the current study 67.5% of the participants prescribe generic medicine due to their quality profile of medicine which is higher than from the findings that reported from Greek, that indicate half of the physicians characterize the quality of generics in terms of efficacy, safety and effectiveness as 'very high' or 'high' when compared with the respective original products. 41 This study implies those socio-demographic factors of physicians like sex, marital status, religion and educational status has had no significant association with generic prescribing behavior, on contrary to our findings the report of Greek revealed Physician's age and opinion on generics' efficacy and effectiveness were identified as important determinants of their prescribing decisions and reports from university of Maryland showed differences in both the propensity of physicians to prescribe generics and in physicians' experiences may arise because of differences in the institutional features of where physicians practice (urban versus rural, group versus single practice, etc.) or because of the demographic characteristics of physicians (age, place of medical education, etc.) or characteristics of their patients. 41, 42 A possible limitation of this study could be the study population used for this study was very small. Second, this survey was conducted only among Physicians working in private health facilities in the Mekelle city. Therefore, the generalizability to physicians practicing in other facilities is somewhat limited. Third, the study is a cross-sectional type and thus it did not investigate cause and effect relationship. Nevertheless, this survey can serve as a preliminary study and is helpful in understanding the belief of Physicians on issues pertaining to generic medicines use in Ethiopia.
CONCLUSION
In conclusion the majority of physicians do not have a positive perception of generic medicines and a significant portion of the physician's belief brand medicines safer and effective than generic counterparts. The main factors affecting the prescription of generic medicines by physicians have been identified in this study: the availability of medicines in pharmacies, low cost of medicines and the basis of purchasing power of the patients.
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